News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Elsevier Business Intelligence to Host "Investment in Innovation (IN3) Medical Device 360° Summit-San Francisco," October 15-17, 2012


7/9/2012 9:09:59 AM

SAN FRANCISCO, CA--(Marketwire - July 09, 2012) - Elsevier Business Intelligence, publisher of "The Gray Sheet" and the medtech industry's leading provider of strategic partnership and investment conferences, will host the 'Investment in Innovation (IN3) Medical Device 360° Summit-San Francisco' strategic partnering and investment conference on October 15-17, 2012, at the InterContinental Mark Hopkins San Francisco. Taking place in the hub of device investment and innovation in the Bay Area, the event will bring together a diverse group of medtech's key thought leaders -- from Corporate Business Development, Venture Capital and Strategic Investment, Start-Up Entrepreneurs and Industry Pioneers -- to candidly discuss the critical issues that will define the future of all players in the evolving device space.

Summit-San Francisco will feature presentations by more than 25 early development- to commercial-stage start-up device companies seeking funding and/or strategic partnership, and an outstanding agenda of expert guest speakers and panels. In addition to the timely opening presentation -- "The 2012 Elections: Impact on FDA, Healthcare Reform and the Future of Medical Technology Innovation" by Mark Leahey, President and CEO, Medical Device Manufacturers Association (MDMA) -- Summit-San Francisco also will feature Thomas J. Fogarty, internationally recognized cardiovascular surgeon, inventor and entrepreneur, who will host a Fireside Chat. Additionally, a special evening presentation will be given by Don Urbanowicz, President, Urbanowicz Consulting: "Top 10 Value Drivers Strategics Look for in Pre-Revenue Start-Ups." Insightful panel topics will include: "Strategics on Deal Priorities: Driving Growth through Different Structures"; "Medtech Investing: What Types of Deals VCs Prefer"; and, "Medtech Investing: Where Is the Capital Going?" Investors confirmed to participate to date include senior-level dealmakers from Aberdare Ventures, Abingworth, Advanced Technology Ventures, Draper Fisher Jurvetson, edbi, Medtronic, MPM Capital, Psilos Group, RCT BioVentures, Three Arch Partners and Versant Ventures, among many others. Partnering software will be available to all registered attendees prior to the conference so that one-on-one on-site meetings can be pre-arranged.

This two-day special event will benefit anyone with a stake in the medical device sector: start-ups seeking investment or strategic partnership, investment firms, VCs, mid-size and large device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in San Francisco should contact Kayleen Kell at 949-797-7142, or email k.kell@elsevier.com.

Event co-sponsors include Ronald Trahan Associates Inc., Aptiv Solutions, Medmarc with The Hartford and Biomedic-Insure, Knobbe Martens, MassMedic Angels, Neocure Group, Life Science Intelligence, Current Partnering and marketwire. Visit www.IN3Summit.com for full conference and registration details.

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.


Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES